Web16 jan. 2024 · Medtronic, through its minority investment portfolio, has been a strategic investor in Affera and currently holds a 3% ownership stake in the company. The acquisition expands the Medtronic portfolio of advanced cardiac ablation products and accessories to meet physician needs within a growing patient population. Web16 mrt. 2024 · Medtronic announced in December that enrollment was completed in Affera SPHERE Per-AF, a randomized, controlled FDA investigational device exemption pivotal trial. That trial, designed to evaluate the safety and effectiveness of the Affera mapping ablation system for the treatment of persistent atrial fibrillation, is currently in its 12 month …
Medtronic to Acquire Affera - ADVFN
WebMedtronic receives CE mark approval of the Affera™ Mapping and Ablation System! Find the latest on Affera technologies and clinical programs by following Medtronic Cardiac … Web15 mrt. 2024 · FRIDLEY (dpa-AFX) - Medtronic plc (MDT) on Wednesday said it received CE mark for the Affera Mapping and Ablation System to treat atrial arrhythmias or fast, … god allows evil
Medtronic (MDT) to Buy Affera, Expand in Electrophysiology
Web2 sep. 2024 · Affera is a medical technology company dedicated to delivering unrivaled innovative solutions to address the rapidly growing demands for cardiac arrhythmia treatment. Affera is developing a comprehensive integrated platform to efficiently deliver durable therapy for a broad set of cardiac arrhythmia patients. Web30 aug. 2024 · Medtronic plc (NYSE: MDT ), a global leader in healthcare technology, today announced that it has completed the acquisition of Affera, Inc. This acquisition expands the company's cardiac ablation ... Web10 jan. 2024 · DUBLIN, Jan. 10, 2024 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced that it has entered into a definitive agreement to acquire Affera, Inc., a Boston area-based, privately held … god all nature sings thy glory hymn